
Company achieves key milestone in drug discovery for rare bone cancer
The Chordoma Foundation’s TBXT Challenge was won by X-Chem, securing the company $100,000 in milestone awards. X-Chem was the first of 26 participating teams to discover a compound that binds Brachyury (TBXT) below the 1 micromolar threshold. TBXT is a key vulnerability in chordoma, a… Read More



